Advancements in our understanding of genetics have the potential to change the practice of medicine and enable genomics-based healthcare. With streamlined workflows and advanced informatics, Illumina sequencing and array technologies and analysis services are allowing you to explore the genome more than ever before.
Together, we can address healthcare in ways never before imagined.
The MiSeqDx System is the first FDA-cleared in vitro diagnostic (IVD) NGS system.
View SystemNew discoveries are rapidly advancing our understanding of disease-causing mutations and genetic predispositions. Leveraging this information in a clinical environment can make it more readily accessible, hopefully leading to better patient care. Illumina offers solutions specific for cystic fibrosis screening and diagnosis, and kits for developing your own assays using next-generation sequencing.
Learn More About Illumina Molecular Diagnostics
Next-generation sequencing technology can help find the underlying genetic component of a disease or health condition.
Read IntroductionInformatics tools enable the translation of next-generation sequencing and array data into meaningful information. Illumina offers a number of tools to simplify analysis and help you easily obtain information relevant to your specific questions.
Learn More About Illumina Informatics Tools